SK Plasma's Indonesia factory to mass produce blood-derived drugs in 2026Published 4 minutes agoSource: asia.nikkei.com This article appears to have no content available. You can try returning to the homepage to browse other articles. Read Original ArticleRelated Articles from asia.nikkei.com4 minutes agoChina carmaker GAC reworks dealer strategy to fend off newcomers4 minutes agoJapan tender offers hit record $68bn as companies restructure4 minutes agoRoomba hit by four-year innovation gap amid China rivalry: CEO4 minutes agoUS Senate passes defense bill targeting China in biotech, investment4 minutes agoNippon Steel steps up U.S. Steel overhaul, seeking hundreds of improvements4 minutes agoJapan brewer Kirin to boost R&D on food and health, open Southeast Asia lab